Kampala, Uganda | THE INDEPENDENT | Injectable HIV drug cabotegravir has been found effective in offering protection against the disease if taken by HIV negative person as a form of Pre-Exposure Prophylaxis (PrEP). In a large scale study code-named HPTN 083 that has been halted because of the coronavirus pandemic, a …
Read More »